<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Mesenchymal Stromal Cells Modulate Monocytes Trafficking in Coxsackievirus B3-Induced Myocarditis</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2017-01-03">3 January 2017.</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Kapka</forename><surname>Miteva</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Kathleen</forename><surname>Pappritz</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Muhammad</forename><surname>El-Shafeey</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Fengquan</forename><surname>Dong</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Jochen</forename><surname>Ringe</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">Laboratory for Tissue Engineering</orgName>
								<orgName type="institution">University Medicine Berlin</orgName>
								<address>
									<addrLine>Charit e</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Carsten</forename><surname>Tscho ¨pe</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">University Medicine Berlin</orgName>
								<address>
									<addrLine>Charit e, Campus Virchow</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Sophie</forename><surname>Van Linthout</surname></persName>
							<email>sophie.van-linthout@charite.de</email>
							<affiliation key="aff1">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">University Medicine Berlin</orgName>
								<address>
									<addrLine>Charit e, Campus Virchow</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>Ph.D</roleName><forename type="first">Sophie</forename><forename type="middle">Van</forename><surname>Linthout</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Berlin- Brandenburg</forename><surname>Center</surname></persName>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="institution">Charit e -University of Medicine Berlin</orgName>
								<address>
									<addrLine>S€ udstrasse 2</addrLine>
									<postCode>13353</postCode>
									<settlement>Regenerative Therapies, Berlin</settlement>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Mesenchymal Stromal Cells Modulate Monocytes Trafficking in Coxsackievirus B3-Induced Myocarditis</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2017-01-03">3 January 2017.</date>
						</imprint>
					</monogr>
					<idno type="MD5">1EF1966077B5BA355BDA2728A8033672</idno>
					<idno type="DOI">10.1002/sctm.16-0353</idno>
					<note type="submission">Received 1 August 2016; accepted for publication 7 November 2016;</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:48+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Myocarditis</term>
					<term>Mesenchymal stromal cells</term>
					<term>Monocytes trafficking</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Mesenchymal stromal cell (MSC) application in Coxsackievirus B3 (CVB3)-induced myocarditis reduces myocardial inflammation and fibrosis, exerts prominent extra-cardiac immunomodulation, and improves heart function.</s><s>Although the abovementioned findings demonstrate the benefit of MSC application, the mechanism of the MSC immunomodulatory effects leading to a final cardioprotective outcome in viral myocarditis remains poorly understood.</s><s>Monocytes are known to be a trigger of myocardial tissue inflammation.</s><s>The present study aims at investigating the direct effect of MSC on the mobilization and trafficking of monocytes to the heart in CVB3-induced myocarditis.</s><s>One day post CVB3 infection, C57BL/6 mice were intravenously injected with 1 x 10 6 MSC and sacrificed 6 days later for molecular biology and flow cytometry analysis.</s><s>MSC application reduced the severity of myocarditis, and heart and blood pro-inflammatory Ly6C high and Ly6C middle monocytes, while those were retained in the spleen.</s><s>Anti-inflammatory Ly6C low monocytes increased in the blood, heart, and spleen of MSC-treated CVB3 mice.</s><s>CVB3 infection induced splenic myelopoiesis, while MSC application slightly diminished the spleen myelopoietic activity in CVB3 mice.</s><s>Left ventricular (LV) mRNA expression of the chemokines monocyte chemotactic protein-1 (MCP)21, MCP-3, CCL5, the adhesion molecules intercellular adhesion molecule-1, vascular cell adhesion molecule-1, the pro-inflammatory cytokines interleukin-6, interleukin-12, tumor necrosis factor-a, the pro-fibrotic transforming growth factorb1, and circulating MCP-1 and MCP-3 levels decreased in CVB3 MSC mice, while LV stromal cell-derived factor-1a RNA expression and systemic levels of fractalkine were increased in CVB3 MSC mice.</s><s>MSC application in CVB3-induced myocarditis modulates monocytes trafficking to the heart and could be a promising strategy for the resolution of cardiac inflammation and prevention of the disease progression.</s><s>STEM CELLS TRANSLATIONAL MEDICINE 2017;6:1249-1261</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>SIGNIFICANCE STATEMENT</head><p><s>Mesenchymal stromal cell (MSC) are leading candidates for cardiac cellular therapy due to their cardioprotective and immunomodulatory properties.</s><s>Despite their well-recognized immunomodulatory features, the effect of MSC on cardiac trafficking of monocytes has still not been investigated.</s><s>The present study reveals that MSC attenuate myocardial inflammation via suppressing the cardiac infiltration of pro-inflammatory monocytes while promoting cardiac influx of antiinflammatory monocytes.</s><s>The present findings are dedicated to extent the knowledge of the immunomodulatory effects of MSC, advancing their potential use for cardiac therapies.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTRODUCTION</head><p><s>Inflammation is a major trigger and a dominant mechanism in the pathogenesis of inflammatory cardiomyopathy and heart failure, evident by the finding that extensive inflammation in patients with acute myocarditis is an independent predictor of a poor outcome <ref type="bibr" target="#b0">[1]</ref>.</s></p><p><s>The immune and inflammatory cell network is emerging as a major inducer of immune cellmediated cardiac injury, which is associated with extreme changes of the mononuclear phagocyte network of the failing heart, spleen, peripheral blood, and bone marrow <ref type="bibr" target="#b1">[2]</ref>.</s><s>In heart failure, the splenic microenvironment plays a major role in the activation and trafficking of innate immune cells to the heart where they induce immune cell-mediated injury.</s><s>Monocytes and macrophages have been recognized as key effector cells after myocardial infarction and in myocarditis <ref type="bibr" target="#b2">[3]</ref>, comprising a major proportion of the heart infiltrating cells and playing a leading role in the pathogenesis <ref type="bibr" target="#b4">[4,</ref><ref type="bibr" target="#b5">5]</ref>.</s><s>Monocytes are a heterogeneous multifunctional cellular population, of which CD115 cells infiltrate to sites of inflammation in response to chemokine signals and differentiate into inflammatory M1 macrophages secreting pro-inflammatory cytokine, such as tumor necrosis factor-a (TNF-a) and interleukin-6 (IL-6) and contribute to tissue degradation and T cell activation <ref type="bibr" target="#b6">[6]</ref>.</s><s>In contrast, the CD115 1 CD11b 1 Ly6-C low CCR2 low CXC3CR1 high monocytes are recruited to the inflamed tissue and are more likely to differentiate into M2 macrophages, which secrete anti-inflammatory cytokines and contribute to tissue repair <ref type="bibr" target="#b6">[6]</ref>.</s></p><p><s>The chemokine system represents the main regulator of leukocyte recruitment <ref type="bibr" target="#b7">[7]</ref>, while the spleen, in addition to the blood, functions as a reservoir of monocytes outside the bone marrow.</s><s>Monocytes are released from splenic reservoir, and Ly6C high monocytes are selectively recruited to the injured heart <ref type="bibr" target="#b8">[8]</ref>.</s><s>Monocyte chemotactic protein-1 (MCP-1/CCL2) and its receptor chemokine (C-C motif) receptor-2 (CCR2) play a leading role in the recruitment of monocytes/macrophages during inflammatory processes in the cardiovascular system <ref type="bibr" target="#b9">[9]</ref>.</s><s>Furthermore, MCP-1 and MCP-3 (also known as CCL7) are CC-chemokines that bind to CCR2 and mediate Ly6C high monocyte recruitment <ref type="bibr" target="#b8">[8,</ref><ref type="bibr" target="#b10">10,</ref><ref type="bibr" target="#b11">11]</ref>.</s><s>Ly6C low monocytes respond to CX3C-chemokine ligand 1 (CX3CL1; also known as fractalkine), which governs Ly6C low monocyte infiltration into the myocardium <ref type="bibr" target="#b11">[11]</ref>.</s></p><p><s>There is a growing body of preclinical and early clinical evidence showing great promise of mesenchymal stromal cell (MSC) therapy in the repair of damaged cardiac tissue <ref type="bibr" target="#b12">[12]</ref><ref type="bibr" target="#b13">[13]</ref><ref type="bibr" target="#b14">[14]</ref>.</s><s>We have demonstrated that MSC have the potential to treat acute coxsackievirus B3 (CVB3)-induced inflammatory cardiomyopathy since MSC cannot be infected with CVB3 and exert antiviral effects <ref type="bibr" target="#b14">[14]</ref>.</s><s>Moreover, intravenous (i.v.) MSC application in CVB3-infected mice reduced CVB3-associated cardiomyocyte apoptosis, myocardial fibrosis and inflammation, and induced prominent systemic immunomodulatory effects as indicated by the induction of IL-10 secreting regulatory T cells and increased CD4 1 CD25 1 FoxP3 1 cells in the spleen as well as in the circulation of CVB3 MSC mice <ref type="bibr">[6-8, 15, 16]</ref>.</s><s>The abovementioned findings clearly demonstrate that MSC application is not only safe and cardioprotective, but also associated with prominent extracardiac immunomodulatory effects in a model of CVB3-induced inflammatory cardiomyopathy.</s></p><p><s>However, the exact mechanism of the MSC-protective effects in viral myocarditis is still not completely understood.</s><s>Since monocytes are known to be a marker and trigger of myocardial tissue inflammation <ref type="bibr" target="#b17">[17]</ref>, the aim of the present study is to evaluate the effect of i.v.</s><s>MSC application on cardiac trafficking of monocytes in murine CVB3-induced myocarditis.</s><s>This study could further give a deeper understanding of the immunomodulatory effects of MSC leading to a final cardioprotective outcome in viral myocarditis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MATERIALS AND METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Murine CVB3-Induced Myocarditis and Cell Application</head><p><s>Eight-week-old male C57BL/6 (Charles Rivers, Wilmington, MA, USA) mice were infected by intraperitoneal injection of 1x10 5 plaque forming units (PFU) of CVB3 virus (Nancy strain).</s><s>Control mice received PBS instead of CVB3.</s><s>One day after CVB3 virus infection, 1 x 10 6 MSC of passage 5 were i.v.</s><s>administrated via the tail vein into C57BL/6 mice.</s><s>All mice were sacrificed on day seven post-CVB3 infection.</s><s>The left ventricle (LV) was harvested and snapfrozen for molecular biology.</s><s>For flow cytometry analysis, heart, blood, and spleen mononuclear cells (MNCs) were isolated.</s><s>The investigation was approved by the ethical committee for the use of experimental animals of Charit e-Medical University, Berlin (Nr:G0094/11) and was performed, in accordance with the principles of laboratory animal care and German animal protection law.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MSC Isolation</head><p><s>Human adult MSC were isolated from iliac crest bone marrow aspirates of eight healthy donors after their written approval according to Binger et al. <ref type="bibr" target="#b18">[18]</ref>.</s><s>MSC were cultured and expanded for injection in Dulbecco's modified Eagle's medium (Biochrom, Berlin, Germany) supplemented with 10% fetal bovine serum (FBS), 1% penicillin/streptomycin, 1% glutamine, 2% HEPES, and 2 ng/ml of basic fibroblast growth factor (Tebu-bio, Offenbach, Germany).</s><s>Cultivated MSC were triple negative for the markers CD45, CD34, and CD11b, but stained positively for the markers CD73, CD29, CD105, CD106, CD90, and CD44.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MNCs Isolation From Mouse Heart, Blood, and Spleen</head><p><s>Cardiac MNCs were isolated from control PBS, control MSC, CVB3 and CVB3 MSC mice, 7 days postinfection using the Neonatal Heart Dissociation Kit (Miltenyi Biotec, Bergisch Gladbach, Germany) and gentleMACS Octo Dissociator (Miltenyi Biotec, Bergisch Gladbach, Germany), according to the manufacturer's instructions.</s><s>Splenocytes were isolated from control PBS, control MSC, CVB3, and CVB3 MSC mice according to Van Linthout et al. <ref type="bibr" target="#b16">[16]</ref>.</s><s>Blood MNCs were isolated from whole blood by density gradient centrifugation using Histopaque-1083 (Sigma, Steinheim, Germany).</s><s>Heart, blood and spleen MNCs were used for the analysis of CD115 1 CD11b 1 Ly6C high CCR2 high CXC3CR1 low , CD115 1 CD11b 1 Ly6C middle CCR2 high CXC3CR1 low , and CD115 1 CD11b 1 Ly6C low CCR2 low CXC3CR1 high monocytes.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Flow Cytometry Analysis</head><p><s>Flow cytometry analysis of heart, blood, and spleen MNCs was performed using the directly conjugated monoclonal mouse antibodies anti-CD115 Alexa488, anti-CD11b PerCP/Cy5.5,</s><s>anti-Ly6C Brilliant Violet 421, anti-CXC3CR1 PE and anti-CCR2 Alexa647 antibody.</s><s>Spleen MNCs were stained with anti-mouse CD11c PercP Cy5.5, anti-mouse F4/80 APC, anti-mouse vascular cell adhesion molecule (VCAM) PE, anti-mouse GM-CSF PE (Biolegend, San Diego, CA), anti-mouse CD4 vio Blue and anti-mouse IL-3 APC (Miltenyi, Bergisch Gladbach, Germany).</s><s>Surface staining was performed according to the manufacturer's instructions.</s><s>Sample analysis was performed on a MACSQuant Analyzer (Miltenyi Biotec, Bergisch Gladbach, Germany) and flow cytometry data were analyzed with FlowJo 8.7.</s><s>software (FlowJo, LLC, RO).</s><s>Supporting Information Figure <ref type="figure" target="#fig_1">1</ref> shows representative flow cytometry analysis of monocytes subsets according to Yang et al. <ref type="bibr" target="#b6">[6]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Gene Expression Analysis</head><p><s>Frozen heart tissue was homogenized with an IKA T25D ULTRA TURRAY homogenisator (Laboratory equipment, Germany) in Trizol, followed by chloroform extraction and isopropanol precipitation.</s><s>Next, RNA was DNase treated with the NucleoSpin RNA II Kit (Macherey-Nagel, D€ uren, Germany) and subsequently reverse transcribed via the High Capacity cDNA Reverse Transcription Kit from Applied Biosystems by Thermo Fisher Scientific (Carlsbad, CA, USA).</s><s>To assess the mRNA expression of the target genes MCP-1, MCP-3, CCL5, stromal cell-derived factor-1a (SDF-1a), IL-6, IL-12, TNF-a, transforming growth factor-ß (TGF-</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ELISA</head><p><s>Plasma from control phosphate buffered saline (PBS), control MSC, CVB3 and CVB3 MSC mice was collected using EDTA and centrifuged at 48C.</s><s>Circulating chemokine MCP-1, MCP-3, and SDF-1a levels were measured via MCP-1, MCP-3, and SDF-1a Enzyme-linked Immunosorbent Assay (ELISA) kits (R&amp;D Systems, Minneapolis, MN) according to the manufacturer's protocol.</s><s>Mouse CX3CL1 levels were determined via the CX3CL1/Fractalkine ELISA kit (Abcam, Cambridge, U.K.) according to the manufacturer's protocol.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Spreading Assay</head><p><s>Spleen MNCs isolated from all experimental groups were resuspended in RPMI 1640 medium containing 10% FBS and 1% penicillin/streptomycin and seeded on CellCarrier 96-well plate coated with 5 lg/ml recombinant mouse (rm) VCAM-1 (Peprotech, Rocky Hill, NJ) for 2 hours at 378C.</s><s>Cells were fixed with BD Cytofix/Cytoperm solution (BD Biosciences, Franklin Lakes, NJ) and stained with Alexa Fluor 546 Phalloidin (Invitrogen Thermo Fisher Scientific, Waltham, MA).</s><s>The spreading assay was performed on a rm VCAM-1 matrix.</s><s>Phase contrast pictures were taken on Zeiss Axio Observer Z1 microscope (Carl Zeiss, Oberkochen, Germany), using AxioVision Rel 4.7 imaging software (Carl Zeiss MicroImaging) and immunofluorescence images were acquired on Operetta High Content Imaging System with Harmony High Content Imaging and Analysis Software (PerkinElmer, MA, USA).</s><s>Cells with flat morphology or lamellipodia were scored positive for spreading.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Myocarditis Score</head><p><s>Hematoxylin and eosin staining was performed on 5 lm thick cryosections.</s><s>We used a semiquantitative scale with severity scores from 0 to 4 to quantify myocardial damage comprising cardiac cell necrosis, inflammation, and scarring according to Savvatis et al. <ref type="bibr" target="#b15">[15]</ref> (score: 0, no inflammatory infiltrates; 1, small foci of inflammatory cells between myocytes; 2, foci &gt;100 inflammatory cells; 3, larger foci with an area 5% of cross-section involved; 4, &gt;5% of a cross-section involved).</s><s>Analysis was made in a blinded manner by digital image analysis on a Leica DMRB microscope (Leica Microsystems, Wetzlar, Germany) at 3100 magnification.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical Analysis</head><p><s>Statistical analysis was performed using Prism 6 for Mac OS X (GraphPad Software, Inc., La Jolla).</s><s>Ordinary one-way ANOVA was used for statistical analysis of the data with correction for multiple comparisons via the Tukey test.</s><s>Data are presented as mean 6 SEM.</s><s>Differences were considered to be significant when the twosided p value was lower than .05.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MSCs Decrease the CVB3-Induced Pro-Inflammatory Monocyte Subsets, While Promoting Anti-Inflammatory Monocytes in the Heart</head><p><s>To evaluate the impact of MSC on the cardiac infiltrating monocyte subsets in CVB3-induced myocarditis, flow cytometry analysis of the pro-and anti-inflammatory monocyte subsets was performed.</s><s>The analysis revealed a 3.4-fold (p &lt; .0001)</s><s>and 2.4-fold (p &lt; .0001)</s><s>increase in the percentage of pro-inflammatory Ly6C high and Ly6C middle monocytes defined as CD115 1 CD11b 1 Ly6-C high CCR2 high CXC3CR1 low and CD115 1 CD11b 1 Ly6C middle CCR2high CXC3CR low , respectively, in CVB3 infected versus control mice.</s><s>Supporting Information Figure <ref type="figure" target="#fig_1">1</ref> illustrates the gating strategy in detail.</s><s>In contrast, MSC application reduced the percentage of Ly6C high and Ly6C middle monocytes in the heart by 2.4-fold (p &lt; .0001)</s><s>and 2-fold (p &lt; .0001)</s><s>compared to CVB3 mice, respectively, suggesting a decreased influx of pro-inflammatory monocytes to the heart after i.v.</s><s>injection of MSC (Fig. <ref type="figure" target="#fig_2">1A, 1B</ref>).</s><s>With respect to the anti-inflammatory monocyte-subset CD115 1 CD11b 1 Ly6C low CCR2 low CXC3CR high , MSC-treated CVB3 mice exhibited a 2.5-fold (p &lt; .05)</s><s>higher percentage of antiinflammatory Ly6C low monocytes in the heart versus CVB3 mice (Fig. <ref type="figure" target="#fig_2">1C, 1D</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MSCs Modulate the Monocyte Subsets in the Blood of CVB3-Infected Mice</head><p><s>To understand how MSC affect the pro-and anti-inflammatory monocytes trafficking to the heart, monocyte subsets were analyzed in the blood.</s><s>In accordance with the observed induction of pro-inflammatory monocyte subsets in the heart of CVB3-infected mice, the percentages of pro-inflammatory Ly6C high and Ly6C middle monocytes were elevated by 13.2-fold (p &lt; .0001)</s><s>and 2.4-fold (p &lt; .01) in CVB3-infected mice in comparison to control mice, respectively (Fig. <ref type="figure" target="#fig_4">2A, 2B</ref>).</s><s>Consistent with the observations in the heart of CVB3 MSC treated mice, the percentages of the proinflammatory Ly6C high and Ly6C middle monocytes declined by 5.4fold (p &lt; .0001)</s><s>and 2.6-fold (p &lt; .01),</s><s>respectively, while the percentage of circulating anti-inflammatory monocytes increased by 2.4-fold (p &lt; .01),</s><s>compared to CVB3 mice (Fig. <ref type="figure" target="#fig_4">2C, 2D</ref>).</s><s>Given the importance of the spleen as a monocytes reservoir, by which splenic monocytes are recruited to the heart upon cardiac injury <ref type="bibr" target="#b8">[8]</ref>, we next evaluated the percentage of proinflammatory and anti-inflammatory monocytes in the spleen of CVB3 mice and the impact of MSC administration on splenic monocyte subsets <ref type="bibr" target="#b1">[2]</ref>.</s><s>The percentage of pro-inflammatory Ly6C high and Ly6C middle monocytes in CVB3-infected mice was augmented by 1.9-fold (p &lt; .01)</s><s>and 2.1-fold (p &lt; .05),</s><s>respectively, in comparison to control mice (Fig. <ref type="figure" target="#fig_5">3A</ref>).</s><s>Interestingly, the presence of pro-inflammatory Ly6C high and Ly6C middle monocytes was 1.5-fold (p &lt; .05)</s><s>higher in the spleen of MSC-treated CVB3 mice compared to CVB3 mice and 1.4-fold (p &lt; .05)</s><s>higher versus control mice.</s><s>In addition, a higher migration potential of splenic MNCs derived from CVB3 mice compared to MNCs derived from CVB3 MSC mice was evident in a spreading assay performed on a rmVCAM-1 matrix (Fig. <ref type="figure" target="#fig_5">3C, 3D</ref>).</s><s>Cells, which exhibited flattened morphology and lamellipodia were considered positive for spreading.</s><s>With respect to Ly6C low monocytes, CVB3 MSC mice exhibited a 1.9-fold (p &lt; .01)</s><s>higher percentage of anti-inflammatory Ly6C low monocytes in the spleen in comparison to CVB3 mice (Fig. <ref type="figure" target="#fig_5">3B</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MSCs Slightly Modulate Splenic Extramedullary Myelopoiesis</head><p><s>VCAM-1 1 macrophages in the splenic red pulp are essential for the extramedullary myelopoiesis and increase the systemic levels of inflammatory leukocytes <ref type="bibr" target="#b19">[19]</ref>.</s><s>To investigate the role of splenic extramedullary myelopoiesis in CVB3-induced myocarditis mice and to further understand the mechanism of the MSC-mediated effects in the spleen, the percentage of splenic CD11b 1 F4/ 80 1 Ly6C -VCAM 1 macrophages was evaluated.</s><s>CVB3 infection resulted in a 1.5-fold (p &lt; .0001)</s><s>higher percentage of splenic VCAM 1 macrophages, while MSC application in CVB3 mice did not have any effect on the percentage of splenic CD11b 1 F4/ 80 1 Ly6C 2 VCAM 1 macrophages (Fig. <ref type="figure" target="#fig_5">3E</ref>).</s><s>Myelopoiesis is also positively regulated by splenic CD4 1 T cells that produce myelopoietic cytokines GM-CSF and IL-3 <ref type="bibr" target="#b20">[20]</ref>.</s><s>Therefore, we next examined the frequencies of CD4 1 GM-CSF 1 and CD4 1 IL-3 1 cells in the spleen of control, control MSC, CVB3, and CVB3 MSC mice.</s><s>CVB3 infection or MSC treatment of CVB3 mice did not affect CD4 1 cells producing the myelopoietic cytokine GM-CSF 1 (Fig. <ref type="figure" target="#fig_5">3F</ref>).</s><s>However, the frequency of CD4 1 IL-3 1 cells increased by 2fold (p &lt; .05)</s><s>(Fig. <ref type="figure" target="#fig_5">3G</ref>) in CVB3-infected mice versus control mice, while CVB3 MSC mice exhibited a 2.4-fold (p &lt; .01)</s><s>lower percentage of CD4 1 IL-3 1 cells.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MSCs Regulate the Trafficking of Monocyte Subsets Through Chemokines Modulation</head><p><s>Considering the importance of chemokines for the recruitment of monocytes <ref type="bibr" target="#b10">[10,</ref><ref type="bibr" target="#b21">21]</ref>, mRNA expression of the chemokines MCP-1, MCP-3, and CCR5, associated with the infiltration of pro-inflammatory monocytes, was analyzed in the heart.</s><s>CVB3infection led to a 90.5-fold (p &lt; .0001),</s><s>124.3-fold (p &lt; .0001)</s><s>and 99.5-fold (p &lt; .001)</s><s>higher LV mRNA expression of MCP-1 (Fig. <ref type="figure" target="#fig_6">4A</ref>), MCP-3 (Fig. <ref type="figure" target="#fig_6">4B</ref>), as well as of CCR5 (Fig. <ref type="figure" target="#fig_6">4C</ref>) versus control mice, respectively.</s><s>In contrast, CVB3-infected mice treated with MSC showed prominent reduction by 51.4-fold (p &lt; .0001),</s><s>225-fold (p &lt; .001),</s><s>and 71.8-fold (p &lt; .001) of LV MCP-1, MCP-3, and CCL5 chemokine expression, respectively, whereas, MSC application in CVB3 mice induced a 3.4-fold (p &lt; .001 vs. CVB3 mice) higher expression of SDF-1a (Fig. <ref type="figure" target="#fig_6">4D</ref>), known to attract cardiac-reparative monocytes.</s><s>To investigate whether the cardiac chemokines expression pattern corresponds with the systemic chemokine levels, MCP-1, MCP-3, SDF-1a, and CX3CR1 were evaluated in the serum.</s><s>A similar trend of chemokine pattern was observed in the serum, CVB3 infection augmented the serum levels of MCP-1 and MCP-3 by 3.9-fold (p &lt; .0001)</s><s>and 3.2-fold (p &lt; .0001)</s><s>respectively, in comparison to control mice, whereas CVB3 MSC mice manifested 3.2-fold (p &lt; .0001)</s><s>and 2.6-fold (p &lt; .01)</s><s>lower MCP-1 and MCP-3 serum levels, respectively, compared to CVB3 mice (Fig. <ref type="figure" target="#fig_7">5A, 5B</ref>).</s><s>The detected SDF-1a did not differ among the groups, but importantly, MSC application in CVB3 mice resulted in 1.4-fold (p &lt; .01 vs. CVB3 mice) higher serum levels of CX3CL1/Fractalkine (Fig. <ref type="figure" target="#fig_7">5C, 5D</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MSCs Abrogate Cardiac Adhesion Molecules Expression in CVB3-Infected Mice</head><p><s>Expression of adhesion molecules such as ICAM-1 and VCAM-1 on endothelial cells promotes leucocyte migration via direct binding to leucocyte cell surface receptors, firm adhesion and guidance of monocyte homing into the inflamed tissue <ref type="bibr" target="#b6">[6,</ref><ref type="bibr" target="#b23">22,</ref><ref type="bibr" target="#b24">23]</ref>.</s><s>Taking the importance of adhesion molecules expression for monocytes adhesion and infiltration into account, LV VCAM-1 and ICAM-1 expression was evaluated.</s><s>As expected, CVB3 infection magnified the LV VCAM-1 and ICAM-1 expression by 6.3-fold (p &lt; .0001)</s><s>and 6.8-fold (p &lt; .0001),</s><s>respectively, in comparison to control mice (Fig. <ref type="figure" target="#fig_8">6A, 6B</ref>), while CVB3 MSC mice exhibited 11.7-fold (p &lt; .0001)</s><s>and 5.1-fold (p &lt; .0001)</s><s>lower expression of VCAM-1 and ICAM-1 versus CVB3 mice, respectively.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MSCs Diminish the Expression of Cardiac Pro-Inflammatory Cytokines and the Pro-Fibrotic Cytokine TGF-b1 in CVB3-Infected Mice</head><p><s>To evaluate whether the observed modulation of proinflammatory monocytes in the heart of CVB3 mice upon MSC  application corresponds with a modulation in cytokine expression, LV mRNA expression of IL-6, IL-12, TNF-a known to be released by Ly6C high monocytes <ref type="bibr" target="#b25">[24]</ref><ref type="bibr" target="#b26">[25]</ref><ref type="bibr" target="#b27">[26]</ref><ref type="bibr" target="#b28">[27]</ref> and by inflammatory M1 macrophages was analyzed.</s><s>CVB3 mice exhibited 30.1-fold (p &lt; .005),</s><s>18.8-fold (p &lt; .0001),</s><s>5.7-fold (p &lt; .0001)</s><s>and 4.8-fold (p &lt; .01)</s><s>upregulated LV mRNA expression of IL-6, TNF-a, IL-12 and TGF-b1 (Fig. <ref type="figure" target="#fig_8">6C-6F</ref>), in comparison to control mice, respectively.</s><s>MSC treatment of CVB3-infected mice downregulated the LV mRNA expression of the pro-inflammatory cytokines IL-6, TNF-a, IL-12, and the pro-fibrotic cytokine TGF-b1 by 86.8-fold (p &lt; .01),</s><s>30.4fold (p &lt; .0001),</s><s>7.4-fold (p &lt; .0001)</s><s>and 5.6-fold (p &lt; .01),</s><s>respectively, compared to CVB3 mice.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MSCs Reduce the Severity of Myocarditis</head><p><s>Histological sections were stained with hematoxylin/eosin to estimate the extent of myocardial damage.</s><s>The pathological score of myocardial damage was significantly higher in the PBS-injected CVB3 mice compared to the MSC-treated CVB3 mice, which displayed a reduced size of inflammatory foci (Fig. <ref type="figure" target="#fig_8">6G, 6H</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p><s>The salient finding of the present study is that i.v.</s><s>MSC application diminishes trafficking of pro-inflammatory monocyte subsets, promotes the migration of anti-inflammatory monocytes toward the heart in CVB3 myocarditis mice via modulation of the local and systemic chemokine pattern, and only mildly affects the splenic myelopoiesis.</s></p><p><s>Myocarditis is characterized by a complex manifestation and pathogenesis associated with a profound inflammatory destruction of the myocardium <ref type="bibr" target="#b26">[25]</ref>.</s><s>However, several clinical trials applying immunosuppressive treatment strategies have been largely disappointing <ref type="bibr" target="#b30">[28]</ref><ref type="bibr" target="#b31">[29]</ref><ref type="bibr" target="#b32">[30]</ref> emphasizing the need for immunomodulatory therapies which could more selectively target the disease.</s><s>Our previous studies demonstrated that MSC application in CVB3infected mice is safe, leads to anti-apoptotic and anti-fibrotic effects, reduces myocardial inflammation, and induces prominent systemic immunomodulation without compromising the virus clearance, which is all translated into improved heart function <ref type="bibr" target="#b15">[15,</ref><ref type="bibr" target="#b16">16,</ref><ref type="bibr" target="#b33">31]</ref>.</s><s>MSC migrate to injured tissues and rapidly disappear after systemic infusion <ref type="bibr" target="#b34">[32,</ref><ref type="bibr" target="#b35">33]</ref> and mediate protective effects without a permanent engraftment <ref type="bibr" target="#b15">[15,</ref><ref type="bibr" target="#b36">34]</ref>.</s><s>Despite the limited engraftment, long-lasting effects of MSC have thus been proposed to be mediated via paracrine secretion of soluble factors or microvesicles, such as exosomes <ref type="bibr" target="#b37">[35]</ref>.</s><s>Factors present at the inflammatory site are critical determinants of the immunosuppressive activity of MSCs <ref type="bibr" target="#b16">[16,</ref><ref type="bibr" target="#b38">36]</ref>, which includes inhibition of immune cells activation, suppression of pro-inflammatory cytokines secretion by activated immune cells, and impairment of the immune cells migratory potential through inhibition of the adhesion molecules and receptors that are responsible for immune cell trafficking <ref type="bibr" target="#b39">[37,</ref><ref type="bibr" target="#b40">38]</ref>.</s><s>MSC mediate immunosuppression via secretion of soluble molecules and cytokines like indoleamine 2,3-dioxygenase, prostaglandin E2, TGF-b, hepatocyte growth factor, interleukin-10, and human leukocyte antigen-G <ref type="bibr" target="#b41">[39]</ref>.</s><s>Moreover, MSC have been shown to directly act on monocytes and induce an immunomodulatory phenotype through the secretion of HGF and potentially factors downstream of the COX2 pathway <ref type="bibr" target="#b42">[40,</ref><ref type="bibr" target="#b43">41]</ref>.</s></p><p><s>Considering the role of monocytes as a marker of myocardial tissue inflammation <ref type="bibr" target="#b17">[17]</ref>, and a trigger of disease progression on the one hand, and the immunomodulatory properties of MSC on the other hand, we investigated the potential of MSC to specifically regulate the pro-as well as anti-inflammatory monocyte subsets in a model of CVB3-induced myocarditis.</s></p><p><s>Systemic monocytosis occurs as a result of an acute or a chronic inflammation, where monocytes are recruited to the inflammatory site to exacerbate the immune activation and inflict tissue damage or to support inflammation resolution <ref type="bibr" target="#b44">[42]</ref>.</s><s>Ly6C high monocytes are rapidly recruited to the heart and initially exert beneficial effects <ref type="bibr" target="#b6">[6,</ref><ref type="bibr" target="#b44">42,</ref><ref type="bibr" target="#b45">43]</ref>.</s><s>However, their persistence is deleterious <ref type="bibr" target="#b46">[44,</ref><ref type="bibr" target="#b47">45]</ref>, while Ly6C low monocytes have anti-inflammatory properties supporting healing <ref type="bibr" target="#b6">[6,</ref><ref type="bibr" target="#b48">46]</ref>.</s><s>Monocytes/macrophages are known to be specifically involved in CVB3-induced myocarditis by maintaining a chronic inflammatory response <ref type="bibr" target="#b49">[47]</ref>.</s><s>In agreement, the present study demonstrates the induction of pro-inflammatory monocyte subsets in the heart, blood, and spleen upon CVB3-infection, which was associated with a profound cardiac expression of inflammatory cytokines and chemokines, and cardiac damage.</s><s>MSC application in CVB3-infected mice diminished the infiltration of proinflammatory monocyte subsets toward the heart and induced Ly6C low monocytes associated with tissue repair, leading to less severe myocarditis <ref type="bibr" target="#b6">[6,</ref><ref type="bibr" target="#b48">46]</ref>.</s><s>In contrast to the decreased Ly6C high monocytes in the heart and blood after MSC application, the percentage of Ly6C high and Ly6C middle monocytes was higher in the spleen of CVB3 MSC compared to CVB3 mice.</s><s>The following observation suggests that MSC retained the pro-inflammatory monocytes in the spleen and used it as a site for storage, decreasing the mobilization of inflammatory monocytes from the spleen, their emigration to the blood and subsequent accumulation into the heart, limiting further immune-mediated cardiac injury.</s><s>In line with this hypothesis, the spreading and lamellipodia of CVB3 MSC-derived splenocytes was decreased in comparison to splenocytes from CVB3 mice, indicating that MSC abrogate the migration potential of splenic MNCs.</s><s>With respect to the increased presence of proinflammatory monocytes in the spleen upon CVB3 infection, we speculate that this is due to the still active generation of monocytes in the spleen at this stage of the inflammatory process or due to postviral sensitization of the immune system, knowing that the spleen is a target of CVB3 infection <ref type="bibr" target="#b50">[48]</ref>.</s><s>In this regard, we have indeed found that CVB3-infected mice had a high hematopoietic stem cell activity in the spleen, as shown by an increase in VCAM-1 1 macrophages and CD4 1 IL-3 1 cells, which are essential for splenic myelopoiesis, retaining the hematopoietic stem cell activity in the spleen <ref type="bibr" target="#b19">[19]</ref>.</s><s>MSC application did not affect CVB3-increased VCAM-1 1 macrophages or CD4 1 GM-CSF 1 cells in the spleen, but diminished the percentage of CVB3-induced CD4 1 IL-3 1 cells, indicating that MSC only mildly affect spleen myelopoiesis.</s><s>We speculate that the increase of pro-inflammatory monocytes in the spleen upon MSC application is due to retention and is not associated with MSC-mediated effects on the spleen myelopoiesis.</s></p><p><s>Leukocytes trafficking is mainly regulated by the chemokine system <ref type="bibr" target="#b7">[7]</ref>.</s><s>CVB3 infection stimulates the expression of MCP-1 in myocardial cells, which subsequently leads to the migration of MNCs <ref type="bibr" target="#b21">[21]</ref>.</s><s>CCR2 and MCP-1/MCP-3 are critical for monocyte mobilization and particularly Ly6C high monocyte recruitment to the injured heart <ref type="bibr" target="#b8">[8,</ref><ref type="bibr" target="#b10">10]</ref>, while Ly6C low monocytes respond to CX3CL1 guiding their infiltration into the myocardium <ref type="bibr" target="#b11">[11]</ref>.</s><s>CCL5 (RANTES) expression is highly upregulated during infection/inflammation and is also important for the trafficking of Ly6C high monocytes expressing its ligand CCR5 <ref type="bibr" target="#b51">[49]</ref>.</s><s>SDF-1a is known to mediate cardioprotection through mobilization of stem cells, cardiac myocyte survival, heart regeneration <ref type="bibr" target="#b52">[50]</ref> and through the recruitment of anti-inflammatory monocytes enhancing the remodeling of the microvascular network <ref type="bibr" target="#b53">[51]</ref>.</s><s>MSC application suppressed the viralinduced cardiac expression of the chemokines MCP-1, MCP-3, and CCL5 recruiting inflammatory monocytes within inflamed tissues <ref type="bibr" target="#b10">[10,</ref><ref type="bibr" target="#b51">49]</ref>.</s><s>In parallel, MSC induced SDF-1a expression in the heart of CVB3-infected mice.</s></p><p><s>Besides modulating the cardiac chemokine pattern, MSC modulated the systemic chemokine levels, reducing the CVB3increased circulating levels of MCP-1 and MCP-3, while promoting the increase in circulating CX3CL1 levels, which regulate the trafficking and mobilization of Ly6C low monocytes into the myocardium <ref type="bibr" target="#b11">[11]</ref>.</s></p><p><s>The inflammatory response is dependent on the activation of adhesive interactions between endothelial cells and leukocytes.</s><s>In this regard, our data reveal that MSC abrogated the CVB3-induced expression of the adhesion molecules ICAM-1 and VCAM-1, resulting in a blocked adhesion and transmigration into the inflamed tissue of Ly6C high monocytes <ref type="bibr" target="#b23">[22,</ref><ref type="bibr" target="#b24">23]</ref> and subsequently, weakened Wiley Periodicals, Inc. on behalf of AlphaMed Press expression of pro-inflammatory cytokines in the failing myocardium.</s><s>Prolonged exposure to inflammatory cytokines exacerbates adverse heart remodeling and enhances myocardial damage <ref type="bibr" target="#b54">[52]</ref>.</s><s>MSC abrogated the CVB3-induced expression of heart proinflammatory cytokines, which corresponded with a diminished presence of pro-inflammatory monocytes subsets in the heart of CVB3 MSC mice Furthermore, LV expression of the pro-fibrotic cytokine TGF-b1 was significantly downregulated in CVB3 MSC mice in contrast to CVB3 mice.</s><s>This finding is in line with our previous finding revealing the anti-fibrotic effect of MSC in a model of CVB3-induced viral myocarditis <ref type="bibr" target="#b15">[15]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CONCLUSION</head><p><s>The present study demonstrates that MSC effectively attenuated myocardial inflammation via suppressing the cardiac infiltration of pro-inflammatory monocytes while promoting cardiac influx of anti-inflammatory monocytes.</s><s>We suggest that MSC modulate monocytes trafficking via regulation of the cardiac and systemic chemokine expression pattern (Fig. <ref type="figure" target="#fig_9">7</ref>).</s><s>Hence, the present study gives deeper insights in how MSC regulate the mobilization and adhesion of monocyte subsets in a model of viral myocarditis.</s><s>This provides new perspectives for the development of therapeutic strategies for inflammatory heart diseases via targeting the monocyte response to improve cardiac repair and healing.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>1250MSC</head><label></label><figDesc><div><p><s>Modulate Monocytes Trafficking O c 2017 The Authors STEM CELLS TRANSLATIONAL MEDICINE published by Wiley Periodicals, Inc. on behalf of AlphaMed Press STEM CELLS TRANSLATIONAL MEDICINE</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.</s></p></div></figDesc><graphic coords="3,125.86,97.17,361.44,613.44" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.</s><s>(See prior page) MSCs decrease pro-inflammatory monocytes subsets and promote anti-inflammatory monocytes in the heart of coxsackievirus B3-infected mice.</s><s>(A): Bar graphs represent the mean 6 SEM of CD115 1 CD11b 1 Ly6C high CCR2 high CXC3CR1 low and CD115 1 CD11b 1 Ly6C middle CCR2 high CXC3CR low positive cells in the heart of control mice (open bar) and CVB3-infected mice (closed bar) injected with PBS or MSC, expressed as the percentage of Ly6C high and Ly6C middle positive cells, respectively, with n 5 8-9 per group and ***, p &lt; .001.</s><s>(B): The panel represents dot plots of cardiac CD115 1 CD11b 1 Ly6C high CCR2 high CXC3CR1 low and CD115 1 CD11b 1 Ly6C middle CCR2 high CXC3CR low positive cells as percentage of Ly6C high or Ly6C middle cells, as indicated.</s><s>(C): Bar graphs represent the mean 6 SEM of CD115 1 CD11b 1 Ly6-C low CCR2 low CXC3CR high positive cells in the heart of control mice (open bar) and CVB3-infected mice (closed bar) injected with PBS or MSC, expressed as the percentage of Ly6C low positive cells with n 5 8-9 per group and *, p &lt; .05. (D): The panel represents dot plots of cardiac antiinflammatory CD115 1 CD11b 1 Ly6C low CCR2 low CXC3CR high positive cells as the percentage of Ly6C low cells, as indicated.</s><s>Abbreviations: CCR2, chemokine (C-C motif) receptor-2; CVB3, coxsackievirus B3; CX3CL1, chemokine (C-X3-C motif) ligand-1; MSC, mesenchymal stromal cell.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 2 .</head><label>2</label><figDesc><div><p><s>Figure 2.</s></p></div></figDesc><graphic coords="5,125.86,97.17,361.44,622.24" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 2 .</head><label>2</label><figDesc><div><p><s>Figure 2. (See prior page) MSCs modulate monocyte subsets in the blood of coxsackievirus B3-infected mice.</s><s>(A): Bar graphs represent the mean 6 SEM of CD115 1 CD11b 1 Ly6C high CCR2 high CXC3CR1 low and CD115 1 CD11b 1 Ly6C middle CCR2 high CXC3CR low positive cells in the blood of control mice (open bar) and CVB3-infected mice (closed bar) injected with PBS or MSC, expressed as the percentage of Ly6C high and Ly6C middle positive cells, respectively with n 5 8-9 per group and **, p &lt; .01;</s><s>***, p &lt; .001.</s><s>(B): The panel represents dot plots of blood CD115 1 CD11b 1 Ly6C high CCR2 high CXC3CR1 low and CD115 1 CD11b 1 Ly6C middle CCR2 high CXC3CR low positive cells as percentage of Ly6C high or Ly6C middle cells, as indicated.</s><s>(C): Bar graphs represent the mean 6 SEM of CD115 1 CD11b 1 LyC6 low CCR2 low CXC3CR high positive cells in the blood of control mice (open bar) and CVB3-infected mice (closed bar) injected with PBS or MSC, expressed as the percentage of Ly6C low positive cells with n 5 8-9 per group and **, p &lt; .01. (D): The panel represents dot plots of blood anti-inflammatory CD115 1 CD11b 1 Ly6-C low CCR2 low CXC3CR high positive cells as the percentage of Ly6C low cells, as indicated.</s><s>Abbreviations: CCR2, chemokine (C-C motif) receptor-2; CVB3, coxsackievirus B3; CX3CL1, chemokine (C-X3-C motif) ligand-1; MSC, mesenchymal stromal cell.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Figure 3 .</head><label>3</label><figDesc><div><p><s>Figure 3. MSCs retain pro-inflammatory monocytes subsets in the spleen, induce anti-inflammatory monocytes and slightly affect the spleen extramedullary myelopoiesis in coxsackievirus B3-infected myocarditis.</s><s>(A): Bar graphs represent the mean 6 SEM of CD115 1 CD11b 1 Ly6-C high CCR2 high CXC3CR1 low and CD115 1 CD11b 1 Ly6C middle CCR2 high CXC3CR low positive cells in the spleen of control mice (open bar) and CVB3infected mice (closed bar) injected with PBS or MSC, expressed as the percentage of Ly6C high and Ly6C middle positive cells, respectively with n 5 8-9 per group and *, p &lt; .05;</s><s>**, p &lt; .01;</s><s>***, p &lt; .001.</s><s>(B): Bar graphs represent the mean 6 SEM of CD115 1 CD11b 1 Ly6C low CCR2 low CXC3CR high positive cells in the spleen of control mice (open bar) and CVB3-infected mice (closed bar) injected with PBS or MSC, expressed as percentage of Ly6C low positive cells with n 5 8-9 per group and **, p &lt; .01;</s><s>***, p &lt; .001.</s><s>(C): Phase contrast pictures of spleen mononuclear cell (MNCs) derived from control mice and CVB3-infected mice injected with PBS or MSC, at 3100 magnification.</s><s>Cells with flat morphology were considered positive for spreading.</s><s>(D): Phalloiding staining of spleen MNCs derived from control mice and CVB3-infected mice injected with PBS or MSCs, at 3100 magnification.</s><s>Cells showing lamellipodia were considered positive for spreading.</s><s>(E): Bar graphs represent the mean 6 SEM of VCAM 1 macrophages in the spleen of control mice (open bar) and CVB3-infected mice (closed bar) injected with PBS or MSC, expressed as the percentage of CD11b 1 F4/80 1 Ly6C 2 cells, with n 5 8-9 per group and *, p &lt; .05;</s><s>**, p &lt; .01;</s><s>***, p &lt; .001.</s><s>(F): Bar graphs represent the mean 6 SEM of CD4 1 GM-CSF 1 in the spleen of control mice (open bar) and CVB3-infected mice (closed bar) injected with PBS or MSC, expressed as the percentage of total mononuclear cells (MNCs), with n 5 5-6 per group and **, p &lt; .01</s><s>(G): Bar graphs represent the mean 6 SEM of CD4 1 IL-3 1 in the spleen of control mice (open bar) and CVB3-infected mice (closed bar) injected with PBS or MSC, expressed as the percentage of total MNCs, with n 5 5-6 per group and *, p &lt; .05;</s><s>**, p &lt; .01.</s><s>Abbreviations: CCR2, chemokine (C-C motif) receptor-2; CVB3, coxsackievirus B3; CX3CL1, chemokine (C-X3-C motif) ligand-1; MSC, mesenchymal stromal cell; VCAM-1, vascular cell adhesion molecule-1.</s></p></div></figDesc><graphic coords="7,68.83,92.69,475.56,503.36" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Figure 4 .</head><label>4</label><figDesc><div><p><s>Figure 4. Mesenchymal stromal cells modulate cardiac chemokines expression in coxsackievirus B3-infected myocarditis mice.</s><s>Bar graphs represent the mean 6 SEM of (A) MCP-1, (B) MCP-3, (C) CCL5, and (D) SDF-1a mRNA expression in the LV of control, CVB3, control MSC, and CVB3 MSC mice, as indicated, with n 5 5-6 per group and *, p &lt; .05;</s><s>***, p &lt; .001.</s><s>Abbreviations: CVB3, Coxsackievirus B3; MCP, monocyte chemotactic protein; MSC, mesenchymal stromal cell; SDF-1a, stromal cell-derived factor-1a.</s></p></div></figDesc><graphic coords="8,101.59,337.32,409.99,377.97" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head>Figure 5 .</head><label>5</label><figDesc><div><p><s>Figure 5. Mesenchymal stromal cells regulate systemic chemokines levels in Coxsackievirus B3-infected myocarditis mice.</s><s>Bar graphs represent the mean 6 SEM of serum (A) MCP-1 (pg/ml), (B) MCP-3 (pg/ml), (C) SDF-1a (ng/ml) and (D) CX3CL1/Fractalkine (ng/ml) levels of control, CVB3, control MSC, and CVB3 MSC mice, with n 5 4-6 per group and *, p &lt; .05;</s><s>**, p &lt; .01;</s><s>***, p &lt; .001.</s><s>Abbreviations: CVB3, Coxsackievirus B3; CX3CL1, chemokine (C-X3-C motif) ligand-1; MCP, monocyte chemotactic protein; MSC, mesenchymal stromal cell; SDF-1a, stromal cell-derived factor-1a.</s></p></div></figDesc><graphic coords="9,101.59,92.69,409.99,367.88" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_8"><head>Figure 6 .</head><label>6</label><figDesc><div><p><s>Figure 6.</s><s>MSCs application abrogates left ventricular expression of adhesion molecules, pro-inflammatory cytokines and the pro-fibrotic cytokine TGF-b1 in coxsackievirus B3-infected mice and improves the pathologic myocarditis score.</s><s>Bar graphs represent the mean 6 SEM of (A) VCAM-1 and (B) ICAM-1, (C) IL-6, (D) TNF-a, (E) IL-12, and (F) TGF-b1 mRNA expression in the LV of control, CVB3, control MSC, and CVB3 MSC mice, as indicated, with n 5 5-6 per group and **, p &lt; .01 and ***, p &lt; .001</s><s>(G) Bar graphs represent the mean 6 SEM of the pathologic score of myocarditis assessed by hematoxylin/eosin staining of control, CVB3, control MSC, and CVB3 MSC mice, as indicated, with n 5 4-5 per group and *, p &lt; .05. (H): Hematoxylin/eosin-stained heart sections of control mice receiving PBS (upper left panel) or MSC (upper right panel), or of CVB3 infected mice receiving PBS (lower left panel) or MSC (lower right panel), at a magnification of 3100.</s><s>Abbreviations: CVB3, coxsackievirus B3; CX3CL1, chemokine (C-X3-C motif) ligand-1; ICAM-1, intercellular adhesion molecule-1; IL, interleukin; MSC, mesenchymal stromal cell; TGF-b1, transforming growth factor-b1; TNF-a, tumor necrosis factor-a; VCAM-1, vascular cell adhesion molecule-1.</s></p></div></figDesc><graphic coords="10,68.83,92.69,475.56,485.44" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_9"><head>Figure 7 .</head><label>7</label><figDesc><div><p><s>Figure 7. Hypothetical scheme how intravenous MSC application modulates monocytes trafficking to the heart in viral myocarditis.</s><s>MSC application abrogated the cardiac expression of the chemokines MCP-1, MCP-3 and CCL5, which attract pro-inflammatory monocytes, and lowered the levels of MCP-1 and MCP-3 in the circulation of CVB3-infected mice.</s><s>In the heart, MSC application further reduced the expression of the adhesion molecules VCAM-1 and ICAM-1 in CVB3 mice.</s><s>These effects led to diminished trafficking and homing of proinflammatory monocytes to the heart, as indicated by the reduced pro-inflammatory monocytes in the blood and heart, as well as the downregulated expression of the pro-inflammatory cytokines IL-6, IL-12, and TNF-a and pro-fibrotic TGF-b in the heart of CVB3-infected mice.</s><s>In parallel, MSC injection increased systemic levels of fractalkine, raising the deployment of anti-inflammatory monocytes to the heart.</s><s>Finally, MSC retained the pro-inflammatory monocyte subsets in the spleen, preventing their mobilization, emigration to the blood and accumulation in the heart, limiting further immune-mediated cardiac injury and promoted spleen anti-inflammatory monocytes.</s><s>Abbreviations: CCR2, chemokine (C-C motif) receptor-2; CVB3, coxsackievirus B3; CX3CL1, chemokine (C-X3-C motif) ligand-1; ICAM-1, intercellular adhesion molecule-1; IL, interleukin; MCP, monocyte chemotactic protein; MSC, mesenchymal stromal cell; TGF-b1, transforming growth factor-b1; TNF-a, tumor necrosis factor-a; VCAM-1, vascular cell adhesion molecule-1.</s></p></div></figDesc><graphic coords="11,143.89,92.69,325.44,267.36" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>1</head><label></label><figDesc><div><p><s>CD11b1 Ly6C high CCR2 high CXC3CR1 low and CD115 1 CD11b 1</s></p></div></figDesc><table><row><cell>a Berlin-Brandenburg Center</cell></row><row><cell>for Regenerative Therapies,</cell></row><row><cell>Charit e, University Medicine</cell></row><row><cell>Berlin, Campus Virchow,</cell></row><row><cell>Berlin, Germany; b DZHK</cell></row><row><cell>(German Center for</cell></row><row><cell>Cardiovascular Research),</cell></row><row><cell>partner site Berlin, Germany;</cell></row><row><cell>Ly6C middle CCR2 high CXC3CR1 low</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">www.StemCellsTM.com O c 2017 The Authors STEM CELLS TRANSLATIONAL MEDICINE published by Wiley Periodicals, Inc. on behalf of AlphaMed Press</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGMENTS</head><p><s>We like to acknowledge the assistance of the BCRT Flow Cytometry Lab and Annika Koschel, Kerstin Puhl, and Marzena Sosnowski (in alphabetical order) for excellent technical assistance.</s><s>This study was supported by the Charit e via a Lydia Rabinowitsch Stipendium to K.M.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>AUTHOR CONTRIBUTIONS</head><p><s>K.M.: conception and design, administrative support, collection and/or assembly of data, data analysis and interpretation, manuscript writing; K.P., M.E.-S., and F.D.: collection and/or assembly of data; J.R.: provision of study material or patients; C.T.: financial support, provision of study material or patients, final approval of manuscript; S.V.L.: conception and design, administrative support, collection and/or assembly of data; data analysis and interpretation, manuscript writing.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCLOSURE OF POTENTIAL CONFLICTS OF INTEREST</head><p><s>The authors indicate no potential conflicts of interest.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Predictors of outcome in patients with suspected myocarditis</title>
		<author>
			<persName><forename type="first">I</forename><surname>Kindermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kindermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kandolf</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="page" from="639" to="648" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Remodeling of the mononuclear phagocyte network underlies chronic inflammation and disease progression in heart failure: Critical importance of the cardiosplenic axis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Ismahil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hamid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Bansal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ Res</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="page" from="266" to="282" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<title level="m" type="main">Monocyte and macrophage heterogeneity in the heart</title>
		<author>
			<persName><forename type="first">M</forename><surname>Nahrendorf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">K</forename><surname>Swirski</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Circ Res</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page" from="1624" to="1633" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Monocytes: Protagonists of infarct inflammation and repair after myocardial infarction</title>
		<author>
			<persName><forename type="first">M</forename><surname>Nahrendorf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Pittet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">K</forename><surname>Swirski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="2437" to="2445" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Monocytes in heart failure: Relationship to a deteriorating immune overreaction or a desperate attempt for tissue repair?</title>
		<author>
			<persName><forename type="first">S</forename><surname>Apostolakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">Y</forename><surname>Lip</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Shantsila</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cardiovasc Res</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="page" from="649" to="660" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Monocyte and macrophage differentiation: Circulation inflammatory monocyte as biomarker for inflammatory diseases</title>
		<author>
			<persName><forename type="first">J</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Yu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biomark Res</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page">1</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">The many roles of chemokines and chemokine receptors in inflammation</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">F</forename><surname>Charo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Ransohoff</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">354</biblScope>
			<biblScope unit="page" from="610" to="621" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Identification of splenic reservoir monocytes and their deployment to inflammatory sites</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">K</forename><surname>Swirski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nahrendorf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Etzrodt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">325</biblScope>
			<biblScope unit="page" from="612" to="616" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Silencing of CCR2 in myocarditis</title>
		<author>
			<persName><forename type="first">F</forename><surname>Leuschner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Courties</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Dutta</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="1478" to="1488" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Tsou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Si</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="page" from="902" to="909" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions</title>
		<author>
			<persName><forename type="first">M</forename><surname>Nahrendorf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">K</forename><surname>Swirski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Aikawa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">204</biblScope>
			<biblScope unit="page" from="3037" to="3047" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Use of mesenchymal stem cells for therapy of cardiac disease</title>
		<author>
			<persName><forename type="first">V</forename><surname>Karantalis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Hare</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ Res</title>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="page" from="1413" to="1430" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROME-THEUS) trial</title>
		<author>
			<persName><forename type="first">V</forename><surname>Karantalis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Difede</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gerstenblith</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ Res</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="page" from="1302" to="1310" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Rationale and design of the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis in Dilated Cardiomyopathy (the POSEIDON-DCM study): A phase I/II, randomized pilot study of the comparative safety and efficacy of transendocardial injection of autologous mesenchymal stem cell vs. allogeneic mesenchymal stem cells in patients with non-ischemic dilated cardiomyopathy</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mushtaq</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Difede</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Golpanian</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cardiovasc Transl Res</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="769" to="780" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Mesenchymal stromal cells but not cardiac fibroblasts exert beneficial systemic immunomodulatory effects in experimental myocarditis</title>
		<author>
			<persName><forename type="first">K</forename><surname>Savvatis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Van Linthout</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Miteva</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">e41047</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Van Linthout</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Savvatis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Miteva</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="2168" to="2178" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction: A possible role for left ventricular remodeling</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Maekawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Anzai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yoshikawa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="241" to="246" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Migration potential and gene expression profile of human mesenchymal stem cells induced by CCL25</title>
		<author>
			<persName><forename type="first">T</forename><surname>Binger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Stich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Andreas</forename><forename type="middle">K</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Exp Cell Res</title>
		<imprint>
			<biblScope unit="volume">315</biblScope>
			<biblScope unit="page" from="1468" to="1479" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Macrophages retain hematopoietic stem cells in the spleen via VCAM-1</title>
		<author>
			<persName><forename type="first">P</forename><surname>Dutta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">F</forename><surname>Hoyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Grigoryeva</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">212</biblScope>
			<biblScope unit="page" from="497" to="512" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">FoxP31 regulatory T cells restrain splenic extramedullary myelopoiesis via suppression of hemopoietic cytokine-producing T cells</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">183</biblScope>
			<biblScope unit="page" from="6377" to="6386" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Y</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">W</forename><surname>Chu</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">J Virol</title>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="page" from="12548" to="12556" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Myocyte signalling in leucocyte recruitment to the heart</title>
		<author>
			<persName><forename type="first">A</forename><surname>Ghigo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Franco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Morello</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cardiovasc Res</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="page" from="270" to="280" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Monocyte-endothelial cell interactions in the development of atherosclerosis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Mestas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Trends Cardiovasc Med</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="228" to="232" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Monocyte-mediated defense against microbial pathogens</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">V</forename><surname>Serbina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Jia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Hohl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annu Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="421" to="452" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands</title>
		<author>
			<persName><forename type="first">R</forename><surname>Barbalat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Locksley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Immunol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="1200" to="1207" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Inflammatory monocytes regulate pathologic responses to commensals during acute gastrointestinal infection</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Grainger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Wohlfert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">J</forename><surname>Fuss</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="713" to="721" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">R</forename><surname>Dunay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Damatta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Fux</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Gr1(1) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii</title>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="306" to="317" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Mason</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>O'connell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Herskowitz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">333</biblScope>
			<biblScope unit="page" from="269" to="275" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">The Myocarditis Treatment Trial: Design, methods and patients enrollment</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Hahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">L</forename><surname>Hartz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Moon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Parrillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Cunnion</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Epstein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">321</biblScope>
			<biblScope unit="page" from="1061" to="1068" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Mesenchymal stromal cells: A promising cell source for the treatment of inflammatory cardiomyopathy</title>
		<author>
			<persName><forename type="first">C</forename><surname>Tschope</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Miteva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">P</forename><surname>Schultheiss</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Pharm Des</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="3295" to="3307" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Therapeutic effects of bone marrow-derived mesenchymal stem cells engraftment on bleomycininduced lung injury in rats</title>
		<author>
			<persName><forename type="first">F</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">F</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">G</forename><surname>Liu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Transplant Proc</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="1700" to="1705" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited longterm engraftment and no ectopic tissue formation</title>
		<author>
			<persName><forename type="first">L</forename><surname>Von Bahr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Batsis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Moll</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stem Cells</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="1575" to="1578" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Mesenchymal stem cells: Immune evasive, not immune privileged</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Ankrum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Ong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Karp</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Biotechnol</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="252" to="260" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Mesenchymal stem cells in regenerative medicine applied to rheumatic diseases: Role of secretome and exosomes</title>
		<author>
			<persName><forename type="first">M</forename><surname>Maumus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Jorgensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Noel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochimie</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="2229" to="2234" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide</title>
		<author>
			<persName><forename type="first">G</forename><surname>Ren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Zhao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Stem Cell</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="141" to="150" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Immunobiology of mesenchymal stem cells</title>
		<author>
			<persName><forename type="first">S</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Death Differ</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="216" to="225" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Human mesenchymal stem cells target adhesion molecules and receptors involved in T cell extravasation</title>
		<author>
			<persName><forename type="first">F</forename><surname>Benvenuto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Voci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Carminati</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stem Cell Res Ther</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">245</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Immunoregulation by mesenchymal stem cells: Biological aspects and clinical applications</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Castro-Manrreza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Montesinos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol Res</title>
		<imprint>
			<biblScope unit="page">394917</biblScope>
			<date type="published" when="2015">2015. 2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Mesenchymal stromal cells impair the differentiation of CD14(11) CD16(-) CD64(1) classical monocytes into CD14(11) CD16(1) CD64(11) activate monocytes</title>
		<author>
			<persName><forename type="first">B</forename><surname>Du Rocher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Mencalha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">E</forename><surname>Gomes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cytotherapy</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="12" to="25" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Induction of immunomodulatory monocytes by human mesenchymal stem cell-derived hepatocyte growth factor through ERK1/2</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Hsu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Leukoc Biol</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="page" from="295" to="303" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Regulation and consequences of monocytosis</title>
		<author>
			<persName><forename type="first">P</forename><surname>Dutta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nahrendorf</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunol Rev</title>
		<imprint>
			<biblScope unit="volume">262</biblScope>
			<biblScope unit="page" from="167" to="178" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Monocytes/macrophages prevent healing defects and left ventricular thrombus formation after myocardial infarction</title>
		<author>
			<persName><forename type="first">S</forename><surname>Frantz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Hofmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Fraccarollo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FASEB J</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="871" to="881" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis</title>
		<author>
			<persName><forename type="first">P</forename><surname>Panizzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">K</forename><surname>Swirski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Figueiredo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="1629" to="1638" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">K</forename><surname>Swirski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Libby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Aikawa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="page" from="195" to="205" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior</title>
		<author>
			<persName><forename type="first">C</forename><surname>Auffray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Fogg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Garfa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">317</biblScope>
			<biblScope unit="page" from="666" to="670" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Lipopolysaccharide suppresses cytokine release from coxsackie virus-infected human monocytes</title>
		<author>
			<persName><forename type="first">A</forename><surname>Henke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">P</forename><surname>Spengler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Stelzner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Res Immunol</title>
		<imprint>
			<biblScope unit="volume">143</biblScope>
			<biblScope unit="page" from="65" to="70" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Secondary heterotypic versus homotypic infection by Coxsackie B group viruses: Impact on early and late histopathological lesions and virus genome prominence</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Z</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Wood</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cardiovasc Pathol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="93" to="102" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Inflammatory monocytes and the pathogenesis of viral encephalitis</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Terry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Getts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Deffrasnes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neuroinflammation</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">270</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">SDF-1 in myocardial repair</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Penn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Pastore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Miller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gene Ther</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="583" to="587" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Spatially localized recruitment of antiinflammatory monocytes by SDF-1alpha-releasing hydrogels enhances microvascular network remodeling</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Krieger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Ogle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcfaline-Figueroa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biomaterials</title>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="page" from="280" to="290" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Inflammation in myocardial diseases</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Marchant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Boyd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Lin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ Res</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="page" from="126" to="144" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<monogr>
		<title level="m">StemCellsTM.com for supporting information available online</title>
				<imprint/>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
